Top Markets
#1 PulseChain PulseChain +45.01%
#2 MarsCoin MarsCoin +17.39%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.92%
#4 RedStone RedStone +15.11%
#5 Bitway Bitway +11.33%
#6 Meteora Meteora +9.28%
#7 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +8.13%
#8 Lighter Lighter +8.05%
#9 SkyAI SkyAI +7.96%
#10 OPENLOOT OPENLOOT +7.58%
Coin of the day
PulseChain PulseChain
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Holy Stone Healthcare Co., Ltd. Holy Stone Healthcare Co., Ltd.

Holy Stone Healthcare Co., Ltd.

4194
Classifica tra le azioni #27895
Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and... Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcerative colitis; CA102N, a receptor-targeted chemotherapy that is in a Phase II trial for metastatic colorectal cancer, as well as in a pre-clinical stage for pancreatic ductal adenocarcinoma and a discovery stage for triple-negative breast cancer; ND108E, a CNS-targeted HA conjugate that is in a pre-clinical trial for Alzheimer’s disease; AMD112, a non-invasive HA-conjugated small molecule therapy that is in a pre-clinical trial for wet age-related macular degeneration and other neovascular retinal diseases; and HylCaryo, a hyaluronic acid (HA)-derived nanoparticle platform in a discovery stage. In addition, the company engages in general investment; development and sale of medical devices; biotechnology services; and patent application for pharmaceutical products. Holy Stone Healthcare Co., Ltd. was founded in 2001 and is headquartered in Taipei, Taiwan.
Prezzo delle azioni
$0.20478574
Capitalizzazione di mercato
$29.89M
Variazione (1 giorno)
2.38%
Variazione (1 anno)
-43.60%
Paese
TW
Scambia Holy Stone Healthcare Co., Ltd. (4194)

Categoria

Healthcare
Rapporto P/B per Holy Stone Healthcare Co., Ltd. (4194)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Holy Stone Healthcare Co., Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Holy Stone Healthcare Co., Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT